A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma Plc's Half year financial report January 1-June 30, 2016 (unaudited)

Herantis Pharma Plc Company release August 25, 2016 at 9:00am Development of Lymfactin® and CDNF proceeds as plannedHerantis Pharma Plc's…

Read More

EU funding application coordinated by Herantis Pharma has passed evaluation phase

EU funding application coordinated by Herantis Pharma has passed evaluation phase Herantis Pharma Plc Company release 8 Aug 2016 at…

Read More

Herantis Pharma receives orphan designation in USA for CDNF for treatment of ALS

Herantis Pharma receives orphan designation in USA for CDNF for treatment of ALS Herantis Pharma Plc Company release 11 July…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.